UJ announces 'promising' discovery of anti-cancer drugs
"However‚ UJ3 requires a 10 times lower dose to kill cancer cells. It also focuses more narrowly on cancer cells‚ so that far fewer healthy cells are killed‚" she said. Apart from needing a much lower dose than an industry standard‚ UJ3 is also much less toxic‚ the university statement said.
From article, (silver thiocyanate phosphine complex among these‚ called UJ3‚ has been successfully tested in rats and in human cancer cells in the laboratory.
In research published in Biometals‚ the university states that UJ3 is shown to be as effective against human esophageal cancer cells‚ as a widely-used chemotherapy drug in use today. Esophageal cancer cells are known to become resistant to current forms of chemotherapy.
“The UJ3 complex is as effective as the industry-standard drug Cisplatin in killing cancer cells in laboratory tests done on human breast cancer and melanoma‚ a very dangerous form of skin cancer‚ as well‚” Professor Marianne Cronjé‚ Head of the Department of Biochemistry at the University of Johannesburg‚ said in a statement.
No comments:
Post a Comment